FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vittorio Gebbia

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Stefania Gori; claudio graiff; Gianluigi Lunardi; Annamaria Molino; Antonio Muggiano; Giuliano Pandoli; Carmine Pinto; Fabio Puglisi; Pierosandro Tagliaferri; Silverio Tomao; Marco Venturini; Oscar Alabiso; Editta Baldini; Enrico Barbato; Giordano Domenico Beretta; Stefano Bravi; Orazio Caffo; Luciano Canobbio; Francesco Carrozza; Saverio Cinieri; Giorgio Cruciani; Massimo Di Maio; Angelo Dinota; Vittorio Gebbia; Lucio Giustini
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
Massimo Di Maio; Morena Fasano; Adolfo Favaretto; Ronald Feld; Raffaella Felletti; Vittorio Fregoni; Ciro Gallo; Vittorio Gebbia; Giovenzio Genestreti; Cesare Gridelli; Natasha B Leighl; Paolo Maione; Gianfranco Mancuso; Alessandro Morabito; Floriana Morgillo; Francesco Perrone; Alberto Ravaioli; Ferdinando Riccardi; Antonio Rossi; Salvatore Siena; Simona Signoriello; Mario Spatafora; Ming Sound Tsao; Rafal Wierzbicki; Yasmin Alam; Roberto Bianco; Charles Butts; Fortunato Ciardiello; Saverio Cinieri
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
Vincenzo Serretta; Rosalinda Allegro; Vincenzo Altieri; Gaetano De Grande; Francesco Ferraù; Rosaria Mazza; Darwin Melloni; Giuseppe Morgia; Federico Nicolosi; Vittorio Gebbia
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vittorio Gebbia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stefania Gori; claudio graiff; Gianluigi Lunardi; Annamaria Molino; Antonio Muggiano; Giuliano Pandoli; Carmine Pinto; Fabio Puglisi; Pierosandro Tagliaferri; Silverio Tomao; Marco Venturini; Oscar Alabiso; Editta Baldini; Enrico Barbato; Giordano Domenico Beretta; Stefano Bravi; Orazio Caffo; Luciano Canobbio; Francesco Carrozza; Saverio Cinieri; Giorgio Cruciani; Massimo Di Maio; Angelo Dinota; Vittorio Gebbia; Lucio Giustini
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
Tumori 2013;99(1):35-8.
2012: Massimo Di Maio; Morena Fasano; Adolfo Favaretto; Ronald Feld; Raffaella Felletti; Vittorio Fregoni; Ciro Gallo; Vittorio Gebbia; Giovenzio Genestreti; Cesare Gridelli; Natasha B Leighl; Paolo Maione; Gianfranco Mancuso; Alessandro Morabito; Floriana Morgillo; Francesco Perrone; Alberto Ravaioli; Ferdinando Riccardi; Antonio Rossi; Salvatore Siena; Simona Signoriello; Mario Spatafora; Ming Sound Tsao; Rafal Wierzbicki; Yasmin Alam; Roberto Bianco; Charles Butts; Fortunato Ciardiello; Saverio Cinieri
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(12):1830-44.
2012: Vincenzo Serretta; Rosalinda Allegro; Vincenzo Altieri; Gaetano De Grande; Francesco Ferraù; Rosaria Mazza; Darwin Melloni; Giuseppe Morgia; Federico Nicolosi; Vittorio Gebbia
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
Clinical genitourinary cancer 2012;10(3):174-9.
2012: Massimo Di Maio; Adolfo Favaretto; Ciro Gallo; Vittorio Gebbia; Pasqualina Giordano; Santi Barbera; Domenico Bilancia; Francesco Carrozza; Anna Ceribelli; Silvio Cigolari; R Costanzo; Bruno Daniele; Gennaro Daniele; Alfonso Illiano; Paolo Maione; Alessandro Morabito; Francesco Perrone; Francovito Piantedosi; Elena Piazza; Maria Carmela Piccirillo; Sergio Federico Robbiati; Gaetano Rocco; Antonio Rossi; C Sandomenico; Simona Signoriello; Cesare Gridelli
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Lung cancer (Amsterdam, Netherlands) 2012;76(3):457-64.
2012: Vittorio Gebbia; Giuseppe Bellavia; Francesco Ferraù; Maria Rosaria Valerio
Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.
Expert opinion on drug safety 2012;11 Suppl 1():S49-59.
2011: Vittorio Gebbia; Vincenzo Serretta; Maria Rosaria Valerio; Nicolò Borsellino
Salvage therapy with oral metronomic cyclophosphamide and methotrexate for castration-refractory metastatic adenocarcinoma of the prostate resistant to docetaxel.
Urology 2011;78(5):1125-30.
2011: Domenico Galetta; Vittorio Gebbia; Evaristo Maiello; Nicola Marzano; Michele Montrone; Giovanni Luigi Pappagallo; Salvatore Pisconti; Antonio Rinaldi; Pietro Rizzo; Nicola Sasso; Nicolò Borsellino; Saverio Cinieri; Antonio Febbraro; Giuseppe Colucci
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE).
Clinical lung cancer 2011;12(6):402-6.
2011: Sandro Pignata; Carmela Pisano; Alberto Ravaioli; Vanda Salutari; Antonella Savarese; Laura Scaltriti; Giovanni Scambia; Paolo Scollo; Roberto Sorio; Stefano Tamberi; Maria Rosaria Valerio; Enrico Aitini; Alba Brandes; Enrico Breda; Pietro Del Medico; Massimo Di Maio; Antonio Febbraro; Gabriella Ferrandina; Antonella Ferro; Luigi Frigerio; Ciro Gallo; Vittorio Gebbia; Stefano Greggi; Francesco Legge; Alessandra Vernaglia Lombardi; Domenica Lorusso; Alessandro Morabito; Pietro Musso; Donato Natale; Francesco Perrone
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(27):3628-35.
2011: D Amadori; B Baconnet; A Barbato; C Barone; Roberto Bordonaro; G Comella; D Gattuso; Vittorio Gebbia; Carlo Milandri; Oriana Nanni; S Salvagni; S Saracchini; P Serra; G Gasparini
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 2011;47(14):2091-8.
2011: Sebastiano Mercadante; Vittorio Gebbia; Fabrizio David; Federica Aielli; Lucilla Verna; Giampiero Porzio; Patrizia Ferrera; Alessandra Casuccio; Corrado Ficorella
Does pain intensity predict a poor opioid response in cancer patients?
European journal of cancer (Oxford, England : 1990) 2011;47(5):713-7.
2011: Paolo Tralongo; Francesco Verderame; Dario Giuffrida; Nicolò Borsellino; Alfredo Butera; Michele Caruso; Francesco Ferraù; Vittorio Gebbia
Cancer patient-centered home care: a new model for health care in oncology.
Therapeutics and clinical risk management 2011;7():387-92.
2011: Laura Doni; Alessandra Perin; Luigi Manzione; Vittorio Gebbia; Rodolfo Mattioli; Giovanni Battista Speranza; Luciano Latini; Aldo Iop; Oscar Bertetto; Francesco Ferraù; Palma Pugliese; Paolo Tralongo; alberto zaniboni; Francesco Di Costanzo
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy.
Critical reviews in oncology/hematology 2011;77(1):70-7.
2010: Vittorio Gebbia; Evaristo Maiello; Francesco Giuliani; Nicolò Borsellino; Carlo Arcara; Giuseppe Colucci
Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the Gruppo Oncologico Italia Meridionale.
American journal of clinical oncology 2010;33(5):461-4.
2010: Sebastiano Mercadante; Vittoria Zagonel; Enrico Breda; Carlo Arcara; Vittorio Gebbia; Giampiero Porzio; Federica Aielli; Fabrizio David; Teresa Gammucci; Filomena Narducci; Gaetano Lanzetta; Rossella Restuccia; Alessandro Lembo; Virginia Passeri; Vladimir Virzì; Alessandra Casuccio
Breakthrough pain in oncology: a longitudinal study.
Journal of pain and symptom management 2010;40(2):183-90.
2010: Vittorio Gebbia; Vito Lorusso; Domenico Galetta; Michele Caruso M; Giuseppe Palomba; Fernando Riccardi; Nicolò Borsellino; Francesco Carrozza; Silvana Leo; Francesco Ferraù; Saverio Cinieri; Gianfranco Mancuso; Sergio Mancarella; Giuseppe Colucci
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Lung cancer (Amsterdam, Netherlands) 2010;69(2):218-24.
2010: Giuseppe Colucci; Roberto Labianca; Francesco Di Costanzo; Vittorio Gebbia; Giacomo Cartenì; Bruno Massidda; Elisa Dapretto; Luigi Manzione; Elena Piazza; Mirella Sannicolò; Marco Ciaparrone; Luigi Cavanna; Francesco Giuliani; Evaristo Maiello; Antonio Testa; Paolo Pederzoli; Massimo Falconi; Ciro Gallo; Massimo Di Maio; Francesco Perrone
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1645-51.
2010: Massimo Di Maio; Nicola Lama; Alessandro Morabito; Egbert F Smit; Vassilis Georgoulias; Koji Takeda; Elisabeth Quoix; Dora Hatzidaki; Floris M Wachters; Vittorio Gebbia; Chun-Ming Tsai; Carlos Camps; Wolfgang Schuette; Paolo Chiodini; Maria Carmela Piccirillo; Francesco Perrone; Ciro Gallo; Cesare Gridelli
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
European journal of cancer (Oxford, England : 1990) 2010;46(4):735-43.
2009: Carmela Pisano; Alessandro Morabito; Roberto Sorio; Enrico Breda; Rossella Lauria; Vittorio Gebbia; Laura Scaltriti; Simona Scalone; Vittorina Zagonel; Stefano Greggi; Gerardo Beneduce; Simona Losito; Ciro Gallo; Massimo Di Maio; Valeria Forestieri; Sandro Pignata
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.
Cancer chemotherapy and pharmacology 2009;64(5):1021-7.
2009: Sebastiano Mercadante; Vittorio Gebbia; Fabrizio David; Federica Aielli; Lucilla Verna; Alessandra Casuccio; Giampiero Porzio; Salvatore Mangione; Patrizia Ferrera
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients.
The journal of pain : official journal of the American Pain Society 2009;10(6):594-600.
2009: Patrizia Vici; Francesco Giotta; Luigi Di Lauro; Mario Brandi; Vittorio Gebbia; Paolo Foggi; Vito Lorusso; Carlo Vitucci; Domenico Sergi; Silvia Ileana Fattoruso; Diana Giannarelli; Giuditta Viola; Serena Corsetti; Giuseppe Colucci; Massimo Lopez
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Anticancer research 2009;29(5):1841-5.
2009: Massimo Di Maio; Paolo Chiodini; Vassilis Georgoulias; Dora Hatzidaki; Koji Takeda; Floris M Wachters; Vittorio Gebbia; Egbert F Smit; Alessandro Morabito; Ciro Gallo; Francesco Perrone; Cesare Gridelli
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1836-43.
2009: Vittorio Gebbia; Cesare Gridelli; Claudio Verusio; Luciano Frontini; Enrico Aitini; Bruno Daniele; Teresa Gamucci; Gianfranco Mancuso; Massimo Di Maio; Ciro Gallo; Francesco Perrone; Alessandro Morabito
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.
Lung cancer (Amsterdam, Netherlands) 2009;63(2):251-8.
2009: Vittorio Gebbia; Gianfranco Mancuso; Lucia Lombardi; Evaristo Maiello
Evolution of therapy decision-making process for advanced non-small cell lung cancer.
Oncology 2009;77 Suppl 1():97-102.
2008: Vittorio Gebbia
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma].
Tumori 2008;94(6):Suppl 31-7.
2008: Sebastiano Mercadante; Giampiero Porzio; Patrizia Ferrera; Fabio Fulfaro; Federica Aielli; Lucilla Verna; Patrizia Villari; Corrado Ficorella; Vittorio Gebbia; Salvatore Riina; Alessandra Casuccio; Salvatore Mangione
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
European journal of pain (London, England) 2008;12(8):1040-6.
2008: Vittorio Gebbia; Domenico Galetta; Vito Lorusso; Michele Caruso; Francesco Verderame; Giuseppe Pezzella; Nicolò Borsellino; Ernesto Durini; Roberto Valenza; Biagio Agostara; Giuseppe Colucci
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Lung cancer (Amsterdam, Netherlands) 2008;61(3):369-77.
2008: Vittorio Gebbia
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
Expert opinion on pharmacotherapy 2008;9(8):1321-37.
2008: Vittorio Gebbia; Carlo Di Gregorio; Marco Attard
Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report.
Journal of medical case reports 2008;2():132.
2007: Ferdinando De Vita; Francesco Giuliani; Michele Orditura; Evaristo Maiello; Gennaro Galizia; Natale Di Martino; F Montemurro; Giacomo Cartenì; Luigi Manzione; Sante Romito; Vittorio Gebbia; Fortunato Ciardiello; Giuseppe Catalano; Giuseppe Colucci
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1354-8.
2007: Evaristo Maiello; Francesco Giuliani; Vittorio Gebbia; A Piano; Roberta Agueli; Giuseppe Colucci
Cetuximab: clinical results in colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi8-10.
2007: Vittorio Gebbia; Francesco Giuliani; Vanna Maria Valori; Roberta Agueli; Giuseppe Colucci; Evaristo Maiello
Cetuximab in squamous cell head and neck carcinomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi5-7.
2007: Vittorio Gebbia; Evaristo Maiello; Francesco Giuliani; Nicolò Borsellino; Michele Caruso; G Di Maggio; Francesco Ferraù; Roberto Bordonaro; Francesco Verderame; Paolo Tralongo; L Di Cristina; Roberta Agueli; P Russo; Giuseppe Colucci
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18 Suppl 6():vi124-7.
2007: Cesare Gridelli; Ciro Gallo; Anna Ceribelli; Vittorio Gebbia; Teresa Gamucci; Fortunato Ciardiello; Francesco Carozza; ADOLFO FAVARETTO; Bruno Daniele; Domenico Galetta; Santi Barbera; Francesco Rosetti; Antonio Rossi; Paolo Maione; Francesco Cognetti; Antonio Testa; Massimo Di Maio; Alessandro Morabito; Francesco Perrone
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
The lancet oncology 2007;8(6):500-12.
2007: Richard J Gralla; Ulrich Gatzemeier; Vittorio Gebbia; Rudolf Huber; Mary O'Brien; Christian Puozzo
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.
Drugs 2007;67(10):1403-10.
2006: Paolo Tralongo; Anna Di Mari; Roberta Agueli; Vittorio Gebbia
Oral vinorelbine may not induce acute pain at the tumor site.
Journal of pain and symptom management 2006;32(3):197-9.
2006: Vittorio Gebbia; Michele Caruso; Nicolò Borsellino; Rosanna Ajello; Maria Lina Tirrito; Maurizio Chiarenza; Roberto Valenza; Francesco Verderame; Francesca Varvara; Antonio Marrazzo; Eugenia Bajardi; Francesco Ferrao; Roberto Bordonaro; Paolo Tralongo
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
Anticancer research 2006;26(4B):3143-50.
2006: Francesco Giuliani; Vittorio Gebbia; Evaristo Maiello; Nicolò Borsellino; E Bajardi; G Colucci
Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii73-7.
2006: Vittorio Gebbia; Francesco Verderame; Francesco Ferraù; Roberto Bordonaro; A Callari; Michele Caruso; Maria Lina Tirrito; Roberto Valenza; Giuseppe Cicero; Nicolò Borsellino; Paolo Tralongo
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii60-5.
2006: Evaristo Maiello; Francesco Giuliani; Vittorio Gebbia; N Di Renzo; Giuseppe Pezzella; Sante Romito; rosanna mallamaci; Massimo Lopez; G Colucci
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii55-9.
2006: Giuseppina Savio; Agata Laudani; Vita Leonardi; Alessio Pepe; Caterina Scianna; Vittorio Gebbia; Biagio Agostara
Treatment of metastatic breast cancer with vinorelbine and docetaxel.
American journal of clinical oncology 2006;29(3):276-80.
2006: Vittorio Gebbia; Salvatore Del Prete; Nicolò Borsellino; Francesco Ferraù; Paolo Tralongo; Francesco Verderame; Vita Leonardi; Elena Capasso; Evaristo Maiello; Roberto Bordonaro; Sergio Stinco; Biagio Agostara; Carlo Barone
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience.
Clinical colorectal cancer 2006;5(6):422-8.
2006: Vittorio Gebbia; Francesco Oniga; Roberta Agueli; Adriano Paccagnella
Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 2():ii83-87.
2006: Sandro Pignata; Giovanni Scambia; Antonella Savarese; Enrico Breda; Paolo Scollo; Rocco De Vivo; Emanuela Rossi; Vittorio Gebbia; Donato Natale; Filomena Del Gaizo; Emanuele Naglieri; Antonella Ferro; Pietro Musso; Alfonso Maria D'Arco; Roberto Sorio; Claudio Pisano; Massimo Di Maio; Giuseppe Signoriello; Annalisa Annunziata; Francesco Perrone
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.
BMC cancer 2006;6():202.
2005: Vittorio Gebbia; Roberta Agueli
Chemotherapy for endometrial carcinoma.
La Tunisie médicale 2005;83 Suppl 12():34-5.
2005: Francesco Giuliani; Stefano Molica; Evaristo Maiello; C Battaglia; Vittorio Gebbia; Maurizio Di Bisceglie; Gianluca Vinciarelli; Nicola Gebbia; Giuseppe Colucci
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).
American journal of clinical oncology 2005;28(6):581-5.
2005: Vito Lorusso; Vittorio Gebbia; Massimiliano Spada; Michele Guida; Grazia Cassano; Cosimo Brunetti; Domenico Germano; Giuseppe Nettis; Giovanni Izzi; Domenico Galetta; Marianna Giampaglia; Nicola Silvestris; Giuseppe Colucci
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
Oncology reports 2005;14(6):1547-51.
2005: Domenico Galetta; Francesco Giotta; Gerardo Rosati; Vittorio Gebbia; Luigi Manzione; Maurizio Di Bisceglie; Nicolò Borsellino; Giuseppe Colucci
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
Anticancer research 2005;25(6C):4445-9.
2005: Massimo Di Maio; Cesare Gridelli; Ciro Gallo; Frances A Shepherd; Francovito Piantedosi; Silvio Cigolari; Luigi Manzione; Alfonso Illiano; Santi Barbera; Sergio Federico Robbiati; Luciano Frontini; Elena Piazza; Giovanni Pietro Ianniello; Enzo Veltri; Federico Castiglione; Francesco Rosetti; Vittorio Gebbia; Lesley Seymour; Paolo Chiodini; Francesco Perrone
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
The lancet oncology 2005;6(9):669-77.
2005: Vittorio Gebbia; Christian Puozzo
Oral versus intravenous vinorelbine: clinical safety profile.
Expert opinion on drug safety 2005;4(5):915-28.
2005: Rosario Vincenzo Iaffaioli; Roberta Formato; Anna Tortoriello; Salvatore Del Prete; Michele Caraglia; G Pappagallo; Agata Pisano; Vittorio Gebbia; F Fanelli; Giovanni Pietro Ianniello; Silvio Cigolari; C Pizza; O Marano; Giuseppe Pezzella; Tonino Pedicini; Antonio Febbraro; P Incoronato; Luigi Manzione; Ettore Ferrari; Nicola Marzano; Stefano Quattrin; Salvatore Pisconti; Guglielmo Nasti; G Giotta; Giuseppe Colucci
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
British journal of cancer 2005;92(9):1621-5.
2005: Evaristo Maiello; Vittorio Gebbia; Francesco Giuliani; Giancarlo Paoletti; Nicola Gebbia; Nicolò Borsellino; Giacomo Cartenì; Giuseppe Pezzella; Luigi Manzione; Sante Romito; Massimo Lopez; G Colucci
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv56-60.
2005: Vittorio Gebbia; D Galetta; F De Marinis
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv123-131.
2005: Cesare Gridelli; Antonio Rossi; D Galetta; Paolo Maione; Carmine Ferrara; Ciro Guerriero; Filomena Del Gaizo; Dario Nicolella; Giuseppe Colantuoni; Vittorio Gebbia; G Colucci
Italian clinical research in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv110-115.
2005: Vito Lorusso; Enrico Crucitta; Nicola Silvestris; G Rosati; Luigi Manzione; Mario De Lena; Sergio Palmeri; Vittorio Gebbia; Sergio Mancarella; A Sobrero; Giuseppe Pezzella; P Comella; A Mangiameli; Domenico Muci
Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium.
Oncology reports 2005;13(2):283-7.
2004: Agata Laudani; Vittorio Gebbia; Vita Leonardi; Giuseppina Savio; Nicolò Borsellino; Maria Pia Cusimano; Caterina Calabria; Rosalba Stefano; Biagio Agostara
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma.
Anticancer research 2004;24(2C):1139-42.
2003: Vittorio Gebbia; Pietro Di Marco; Pietro Citarrella
Systemic chemotherapy in elderly patients with locally advanced and/or inoperable squamous cell carcinoma of the head and neck: impact of anemia and role of recombinant human erythropoietin.
Critical reviews in oncology/hematology 2003;48(Suppl):S49-55.
2003: Francesco Giuliani; Vittorio Gebbia; Ferdinando De Vita; Evaristo Maiello; Maurizio Di Bisceglie; Giuseppe Catalano; Nicola Gebbia; Giuseppe Colucci
Docetaxel as salvage therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico Italia Meridionale (G.O.I.M.).
Anticancer research 2003;23(5b):4219-22.
2003: Cesare Gridelli; Ciro Gallo; Frances A Shepherd; Alfonso Illiano; Francovito Piantedosi; Sergio Federico Robbiati; Luigi Manzione; Santi Barbera; Luciano Frontini; Enzo Veltri; Brian Findlay; Silvio Cigolari; Robert Myers; Giovanni Pietro Ianniello; Vittorio Gebbia; Giampietro Gasparini; Sergio Fava; Vera Hirsh; Andrea Bezjak; Lesley Seymour; Francesco Perrone
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3025-34.
2003: Vittorio Gebbia; Pietro Di Marco; Nicolò Borsellino; Nicola Gebbia; Maria Rosaria Valerio; Giuseppina Fallica; Maria Lina Tirrito; Roberto Valenza; Pietro Citarrella; Pierluigi Benedetti Panici
Escalating doses of paclitaxel and epirubicin in combination with cisplatin in advanced ovarian epithelial carcinoma: a phase I-II study.
Anti-cancer drugs 2003;14(5):359-64.
2003: Sebastiano Mercadante; M Bianchi; Patrizia Villari; Patrizia Ferrera; Alessandra Casuccio; Fabio Fulfaro; Vittorio Gebbia
Opioid plasma concentration during switching from morphine to methadone: preliminary data.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(5):326-31.
2003: Cesare Gridelli; Francesco Perrone; Ciro Gallo; Silvio Cigolari; Antonio Rossi; Francovito Piantedosi; Santi Barbera; Francesco Ferraù; Elena Piazza; Francesco Rosetti; Maurizia Clerici; Oscar Bertetto; Sergio Federico Robbiati; Luciano Frontini; Cosimo Sacco; Federico Castiglione; ADOLFO FAVARETTO; Silvia Novello; Maria Rita Migliorino; Giampietro Gasparini; Domenico Galetta; Rosario Vincenzo Iaffaioli; Vittorio Gebbia
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
Journal of the National Cancer Institute 2003;95(5):362-72.
2003: Antonio Rossi; Cesare Gridelli; Vittorio Gebbia; Gerardo Rosati; Anna Tortoriello; Paolo Maione; Nicolò Borsellino; Nestore Rossi; Agata Pisano; Giuseppe Colantuoni; Rosario Vincenzo Iaffaioli; Vincenzo Castaldo; Luigi Manzione
Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.
Anticancer research 2003;23(2C):1657-64.
2003: Vittorio Gebbia; Domenico Galetta; Michele Caruso; Francesco Verderame; Giuseppe Pezzella; Matteo Valdesi; Nicolò Borsellino; Giuseppe Pandolfo; Ernesto Durini; Massimo Rinaldi; Michele Loizzi; Nicola Gebbia; Roberto Valenza; Maria Lina Tirrito; Francesca Varvara; Giuseppe Colucci
Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
Lung cancer (Amsterdam, Netherlands) 2003;39(2):179-89.
2003: Giorgio Cocconi; Rodolfo Passalacqua; S Foladore; Paolo Carlini; Luigi Acito; Evaristo Maiello; M Marchi; Vittorio Gebbia; S Di Sarra; M Beretta; M Bacchi
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
Melanoma research 2003;13(1):73-9.
2003: Vittorio Gebbia; Livio Blasi; Nicolò Borsellino; Michele Caruso; Vita Leonardi; Biagio Agostara; Roberto Valenza
Paclitaxel and epidoxorubicin or doxorubicin versus cyclophosphamide and epidoxorubicin as first-line chemotherapy for metastatic breast carcinoma: a randomised phase II study.
Anticancer research 2003;23(1B):765-71.
2003: Vittorio Gebbia; Nicolò Borsellino; Antonio Testa; Maria Lina Tirrito; Patrizia Ferrera; Alfredo Colombo; Gaetano Mauceri; Antonio Marrazzo; Ferdinando Porretto; Maurizio Musso
Phase I-II parallel study of docetaxel on a bimonthly schedule in refractory metastatic breast carcinoma.
Breast cancer research and treatment 2003;77(2):99-108.
2002: Domenico Galetta; Vittorio Gebbia; Francesco Giotta; Ernesto Durini; Sante Romito; Nicolò Borsellino; Carlo Cazzato; Giuseppe Pezzella; Giuseppe Colucci
Gemcitabine and docetaxel every 2 weeks in advanced non-small cell lung cancer: a phase II study of the Gruppo Oncologico Italia Meridionale.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):79-84.
2002: Vittorio Gebbia; Domenico Galetta; Fernando Riccardi; Cesare Gridelli; Ernesto Durini; Nicolò Borsellino; Nicola Gebbia; Matteo Valdesi; Michele Caruso; Roberto Valenza; Giuseppe Pezzella; Giuseppe Colucci
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
Lung cancer (Amsterdam, Netherlands) 2002;37(2):179-87.
2002: Patrizia Vici; Giuseppe Colucci; Vittorio Gebbia; Antonella Amodio; Francesco Giotta; Franca Belli; Francesca Conti; Nicola Gebbia; Giuseppe Pezzella; Maria Rosaria Valerio; Mario Brandi; Salvatore Pisconti; Ernesto Durini; Diana Giannarelli; Massimo Lopez
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2689-94.
2002: Pietro Citarrella; Vittorio Gebbia; Michele Teresi; Salvatore Miceli; Giovanna Sciortino; Marina Vaglica; Nicolina Pizzardi; Sergio Palmeri
Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report.
Anticancer research 2002;22(2B):1183-5.
2002: Giuseppe Colucci; Francesco Giuliani; Vittorio Gebbia; Maria Biglietto; Pier Giorgio Rabitti; Generoso Uomo; Silvio Cigolari; Antonio Testa; Evaristo Maiello; Massimo Lopez
Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
Cancer 2002;94(4):902-10.
2002: Vittorio Gebbia; Michele Caruso; Antonio Testa; Gaetano Mauceri; Nicolò Borsellino; Maurizio Chiarenza; Nicolina Pizzardi; Sergio Palmeri
Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix.
Oncology 2002;63(1):31-7.
2002: Vittorio Gebbia; Gaetano Mauceri; Giuseppina Fallica; Nicolò Borsellino; Maria Lina Tirrito; Antonio Testa; Francesca Varvara; Alfredo Colombo; Patrizia Ferrera
Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation.
Oncology 2002;63(1):23-30.
2001: Cesare Gridelli; Carlo Curcio; Rosario Vincenzo Iaffaioli; Luigi Brancaccio; Modesto D'Aprile; Vittorio Gebbia; Antonio Rossi; Anna Tortoriello; Enzo Veltri; Paolo Maione; A Barbarisi; Ciro Gallo; Cesare Guida; Francesco Perrone
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Anticancer research 2001;21(6A):4179-83.
2001: Vittorio Gebbia; Francesco Giuliani; Evaristo Maiello; Giuseppe Colucci; Francesco Verderame; Nicolò Borsellino; Gaetano Mauceri; M Caruso; Maria Lina Tirrito; Matteo Valdesi
Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(20):4089-91.
2001: Sergio Palmeri; Vita Leonardi; Vittorio Gebbia; Manuela Tamburo De Bella; Francesco Ferraù; G Faillú; M Spatafora; Roberto Valenza; G Di Vita; S Vitello; R Carroccio; G Sciortino; Marina Vaglica; Vincenzo Accurso; Biagio Agostara; G Licata
Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):115-23.
2001: Vittorio Gebbia; Antonio Testa; Nicolò Borsellino; Patrizia Ferrera; Maria Lina Tirrito; Sergio Palmeri
Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):767-72.
2001: Sebastiano Mercadante; Alessandra Casuccio; Fabio Fulfaro; L Groff; Roberto Boffi; Patrizia Villari; Vittorio Gebbia; Carla Ripamonti
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2898-904.
2000: Evaristo Maiello; Vittorio Gebbia; Francesco Giuliani; Giancarlo Paoletti; Nicola Gebbia; Silvio Cigolari; S Fortunato; Tonino Pedicini; Nicolò Borsellino; Massimo Lopez; Giuseppe Colucci
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1045-51.
2000: Sebastiano Mercadante; Vittorio Gebbia; Antonio Marrazzo; S Filosto
Anaemia in cancer: pathophysiology and treatment.
Cancer treatment reviews 2000;26(4):303-11.
2000: Roberto Valenza; Vita Leonardi; Vittorio Gebbia; Biagio Agostara
Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(4):495-6.
1999: Vittorio Gebbia; Nicolò Borsellino; Antonio Testa; Maria Lina Tirrito; Francesca Varvara; A Cucchiara; Gaetano Mauceri; A Girlando; M Ferrara; F Caruso
Treatment of refractory metastatic breast cancer with 5-fluorouracil plus levofolinic acid as continuous venous infusion: a phase II study.
Anticancer research 1999;19(4C):3553-7.
1999: Giuseppe Colucci; Francesco Giuliani; Vittorio Gebbia; Antonio Testa; Nicolò Borsellino; Giorgio Lelli; S Fortunato; M Lopez; Evaristo Maiello; Nicola Gebbia
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
American journal of clinical oncology 1999;22(3):262-6.
1999: Vittorio Gebbia; Gaetano Mauceri; Antonio Testa; Maria Lina Tirrito; Francesca Varvara; A Cucchiara; Nicolò Borsellino; A Girlando; M Ferrara; F Caruso
Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
Anticancer research 1999;19(3B):2289-92.
1999: Vittorio Gebbia; Evaristo Maiello; G Serravezza; Francesco Giotta; Antonio Testa; Nicolò Borsellino; Giuseppe Pezzella; Giuseppe Colucci
5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Anticancer research 1999;19(2B):1407-10.
1999: Giuseppe Colucci; Evaristo Maiello; Vittorio Gebbia; Francesco Giuliani; G Serravezza; Giorgio Lelli; Silvana Leo; Gianfranco Filippelli; GP Nicolella; M Brandi
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
Cancer 1999;85(3):535-45.
1999: Vittorio Gebbia; Antonio Testa; Nicolò Borsellino; Gaetano Mauceri; Francesca Varvara; Maria Lina Tirrito; D Sambataro; Giuseppina Fallica
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.
La Clinica terapeutica 1999;150(1):11-5.
1998: C Di Gregorio; A M Florena; Vittorio Gebbia; Francesco Moschella
Mental nerve invasion by basal cell carcinoma of the chin: a case report.
Anticancer research 1998;18(6B):4723-6.
1998: Evaristo Maiello; Vittorio Gebbia; Francesco Giuliani; Antonio Testa; Francesco Giotta; Nicola Gebbia; Giuseppe Colucci
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma.
La Clinica terapeutica 1998;149(5):351-5.
1998: Emanuele Naglieri; Vittorio Gebbia; Ernesto Durini; Giorgio Lelli; Ines Abbate; Francesco Paolo Selvaggi; Pasquale Di Tonno; Giuseppe Colucci
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma.
Anticancer research 1998;18(3B):2021-6.
1998: Emilio Bajetta; Maria Di Bartolomeo; Carlo Carnaghi; Roberto Buzzoni; Luigi Mariani; Vittorio Gebbia; Giuseppe Comella; Graziella Pinotti; Giovanni Pietro Ianniello; Giuseppe Schieppati; A M Bochicchio; Luigi Maiorino
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
British journal of cancer 1998;77(7):1149-54.
1997: Vittorio Gebbia; Nicolò Borsellino; Antonio Testa; Mario Adelfio Latteri; V Milia; Matteo Valdesi; Francesco Giotta; Nicola Gebbia; Giuseppe Colucci
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM).
Anti-cancer drugs 1997;8(10):943-8.
1997: Vittorio Gebbia; G Mantovani; Antonio Farris; Biagio Agostara; A Desogus; L Curreli; Francesco Moschella; C Di Gregorio; Emilio Bajetta; Nicola Gebbia
Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study.
Cancer 1997;79(7):1394-400.
1997: Giuseppe Colucci; Francesco Giotta; Vittorio Gebbia; Fernando Riccardi; Giuseppe Pezzella; Ernesto Durini; Michele Caruso; Sante Romito; Nicola Gebbia
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group.
Anti-cancer drugs 1997;8(3):257-64.
1997: Giuseppe Colucci; Vittorio Gebbia; Domenico Galetta; Fernando Riccardi; S Cariello; Nicola Gebbia
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
British journal of cancer 1997;76(11):1509-17.
1996: Cesare Gridelli; Modesto D'Aprile; Sergio Palmeri; C Curcio; Antonio Rossi; Vittorio Gebbia; E Veltri; R Pepe; G Pistillucci; Angelo Raffaele Bianco
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
American journal of clinical oncology 1996;19(6):589-91.
1996: Cesare Gridelli; Francesco Perrone; Sergio Palmeri; Modesto D'Aprile; Francesco Cognetti; Antonio Rossi; Vittorio Gebbia; R Pepe; E Veltri; G Airoma; A Russo; P Incoronato; A F Scinto; G Palazzolo; M Natali; Vita Leonardi; Ciro Gallo; Sabino De Placido; Angelo Raffaele Bianco
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):821-6.
1996: Vittorio Gebbia; E Majello; Antonio Testa; Giuseppe Pezzella; S Giuseppe; Francesco Giotta; F Riccardi; S Fortunato; Giuseppe Colucci; Nicola Gebbia
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Cancer 1996;78(6):1300-7.
1996: Evaristo Maiello; Francesco Giotta; Vittorio Gebbia; Antonio Testa; D Galetta; F Riccardi; Nicola Gebbia; Giuseppe Colucci
Mitomycin C and lonidamine as second-line treatment of advanced colorectal cancer patients.
Anticancer research 1996;16(5B):3177-9.
1996: Vittorio Gebbia; Antonio Testa; G Cannata; Nicola Gebbia
Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
Anti-cancer drugs 1996;7(7):734-7.
1996: Giuseppe Colucci; Evaristo Maiello; Vittorio Gebbia; R A Cifarelli; M Biglietto; A Pedicini; Ernesto Durini; Francesco Giuliani; Nicola Gebbia
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM).
Oncology 1996;53(4):269-74.
1996: Vittorio Gebbia; Antonio Testa; E Majello; G Cannata; Maria Lina Tirrito; G Mastrandrea; M Feo; G Bajardi; Giuseppe Colucci; Nicola Gebbia
Subcutaneous low-dose interleukin-2 and intravenous 5-fluorouracil plus high-dose levofolinic acid as salvage treatment for metastatic colorectal carcinoma.
Anti-cancer drugs 1996;7(4):386-91.
1996: Vittorio Gebbia; Antonio Testa; Nicola Gebbia
Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
British journal of cancer 1996;73(12):1576-80.
1996: Vittorio Gebbia; D Galetta; E Majello; roberto valenza; Giuseppe Colucci; Nicola Gebbia
Treatment of stage III-IV non-small-cell lung carcinoma with vinorelbine in combination with ifosfamide plus MESNA: a study by the Southern Italy Oncology Group (GOIM).
American journal of clinical oncology 1996;19(3):278-80.
1996: Vittorio Gebbia; Antonio Testa; G Cannata; Nicola Gebbia
Single agent paclitaxel in advanced squamous cell head and neck carcinoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):901-2.
1995: Vittorio Gebbia; Giovanni Mantovani; Biagio Agostara; A Contu; Antonio Farris; Giuseppe Colucci; F Cognetti; G Restivo; R Speciale; B Ferrero
Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(10):987-91.
1995: Vittorio Gebbia; Antonio Testa; roberto valenza; G Cannata; Maria Lina Tirrito; Nicola Gebbia
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial.
Cancer 1995;76(10):1821-8.
1995: Giuseppe Colucci; S Romito; Vittorio Gebbia; G Pacilio; Francesco Giotta; Antonio Testa; Giuseppe Pezzella; Ernesto Durini; Biagio Agostara; S Cariello
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
British journal of cancer 1995;72(5):1245-50.
1995: M A Latteri; C Cipolla; Vittorio Gebbia; G Lampasona; C Amato; Nicola Gebbia
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(4):432-4.
1995: Vittorio Gebbia; Antonio Testa; C Di Gregorio; F Ingria; roberto valenza; G Cannata; Francesco Moschella; G Restivo; Nicola Gebbia
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck.
American journal of clinical oncology 1995;18(4):293-6.
1995: C Di Gregorio; Vittorio Gebbia; A M Florena; Vito Franco; Francesco Moschella
Perineural infiltration by cutaneous squamous cell carcinomas of the head and neck.
Anticancer research 1995;15(3):1107-15.
1994: Vittorio Gebbia; roberto valenza; Antonio Testa; C Cipolla; M Latteri; G Curto; S Comande; C Buccellato; Nicola Gebbia
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas.
American journal of clinical oncology 1994;17(6):485-9.
1994: Vittorio Gebbia; G Cannata; Antonio Testa; G Curto; roberto valenza; C Cipolla; M A Latteri; Nicola Gebbia
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial.
Cancer 1994;74(7):1945-52.
1994: Vittorio Gebbia; roberto valenza; Antonio Testa; Nicolò Borsellino; G Cannata; S Restivo; R Speciale; F Ingria; G Spadafora; Nicola Gebbia
Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
ORL; journal for oto-rhino-laryngology and its related specialties 1994;56(5):279-82.
1994: Vittorio Gebbia; M Caruso; roberto valenza; Antonio Testa; G Cannata; F Verderame; C Cipolla; G Curto; D Oliveri; M Chiarenza
Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma.
Anticancer research 1994;14(3B):1247-9.
1994: Vittorio Gebbia; Antonio Testa; roberto valenza; M Latteri; G Bajardi; G Mastrandrea; C Cipolla; G Pischedda; G Curto; G Cannata
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomach.
Journal of chemotherapy (Florence, Italy) 1994;6(2):147-51.
1994: Vittorio Gebbia; roberto valenza; Antonio Testa; G Cannata; Nicolò Borsellino; Nicola Gebbia
A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy.
Anticancer research 1994;14(2B):731-4.
1994: Biagio Agostara; Vittorio Gebbia; Antonio Testa; M P Cusimano; Nicola Gebbia; A M Callari
Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinoma.
Tumori 1994;80(1):33-6.
1994: Vittorio Gebbia; roberto valenza; Antonio Testa; C Sciume; A Longo; C Cipolla; Nicolò Borsellino; P Leo; M Latteri; M Florena
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
Journal of cancer research and clinical oncology 1994;120(9):550-2.
1994: Vittorio Gebbia; Antonio Testa; roberto valenza; G Cannata; F Verderame; Nicola Gebbia
Acute pain syndrome at tumour site in neoplastic patients treated with vinorelbine: report of unusual toxicity.
European journal of cancer (Oxford, England : 1990) 1994;30A(6):889.
1994: Vittorio Gebbia; roberto valenza; Antonio Testa; G Cannata; F Verderame; Nicola Gebbia
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(11):1734-6.
1994: A Callari; Vittorio Gebbia; Antonio Testa; M P Cusimano; C Cipolla; C Amato; G Cannata; M A Latteri; C Garascia; Nicola Gebbia
A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma.
Acta oncologica (Stockholm, Sweden) 1994;33(8):925-9.
1993: Vittorio Gebbia; Antonio Testa; roberto valenza; G Zerillo; S Restivo; G Cupido; F Ingria; C Barbaccia; G Spadafora; G Cannata
A phase II study of levofolinic acid and 5-fluorouracil plus cisplatin in patients with advanced head and neck squamous cell carcinoma.
Oncology 1993;50(6):490-4.
1993: Vittorio Gebbia; Antonio Testa; Nicolò Borsellino; G Cannata; roberto valenza; Nicola Gebbia
Pharmacological modulation of 5-fluorouracil and its clinical implications: an overview.
In vivo (Athens, Greece) 1993;7(6B):639-44.
1993: Vittorio Gebbia; I Carreca; Antonio Testa; roberto valenza; G Curto; G Cannata; Nicolò Borsellino; M A Latteri; C Cipolla; M Florena
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.
Anti-cancer drugs 1993;4(4):443-5.
1993: Vittorio Gebbia; Biagio Agostara; A Callari; G Zerillo; G Restivo; R Speciale; G Cupido; F Ingria; G Spatafora; L Fazio
Head and neck carcinoma with distant metastases: a retrospective analysis of 44 cases treated with cisplatin-based chemotherapeutic regimens.
Anticancer research 1993;13(4):1129-31.
1993: Vittorio Gebbia; G Zerillo; G Restivo; R Speciale; G Cupido; P Lo Bue; F Ingria; S Gallina; G Spatafora; Antonio Testa
Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.
British journal of cancer 1993;68(1):191-4.
1993: Vittorio Gebbia; Antonio Testa; roberto valenza; Nicolò Borsellino; C Cipolla; G Cannata; G Curto; M Latteri; M Florena; Nicola Gebbia
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma.
Journal of chemotherapy (Florence, Italy) 1993;5(3):186-90.
1993: Antonio Russo; Vittorio Gebbia; Sergio Palmeri; P Geraci; F Maneschi; G Guarnieri; F Carollo; Vita Leonardi; Maria Meli; Nicola Gebbia
Results of the combination of cisplatin, adriamycin and cyclophosphamide in the treatment of ovarian carcinoma.
European journal of gynaecological oncology 1993;14(3):228-33.
1993: Vittorio Gebbia; Antonio Testa; roberto valenza; C Cipolla; C Amato; M Latteri; Nicola Gebbia; M Florena
Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma.
Anticancer research 1993;13(1):141-4.
1993: Vittorio Gebbia; Antonio Testa; roberto valenza; G Zerillo; S Restivo; F Ingria; G Cannata; Nicola Gebbia
A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1358-9.
1992: Vittorio Gebbia; Nicola Gebbia; Antonio Russo; Antonio Testa; roberto valenza; G Zerillo; F Ingria; G Spadafora; Luciano Rausa
Hydroxyurea modulates 5-fluorouracil antineoplastic activity in advanced head and neck carcinoma pretreated with chemotherapy.
Anti-cancer drugs 1992;3(4):347-9.
1992: Vittorio Gebbia; G Zerillo; Nicola Gebbia; Biagio Agostara; A Callari; Luciano Rausa
Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease.
Journal of chemotherapy (Florence, Italy) 1992;4(4):244-59.
1992: Vittorio Gebbia; P Citarrella; V Miserendino; roberto valenza; Nicolò Borsellino; A Pesta; R Pettit; S May
The effects of the macrocyclic lactone bryostatin-1 on leukemic cells in vitro.
Tumori 1992;78(3):167-71.
1992: P Citarrella; Vittorio Gebbia; P Di Marco; M Tambone Reyes; G Noto; Mario Aricò
Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy.
Journal of chemotherapy (Florence, Italy) 1992;4(1):56-8.
1992: Vittorio Gebbia; Antonio Russo; Nicola Gebbia; Luciano Rausa; F Ingria; G Spatafora; G Zerillo; A Cimino; T Pastorello; P Ferrara
High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck.
Journal of cancer research and clinical oncology 1992;118(6):458-62.
1992: Sergio Palmeri; Vittorio Gebbia; Antonio Russo; Nicola Gebbia; Y Rustum; Luciano Rausa
Cisplatinum in combination with 5-fluorouracil and citrovorum factor in the treatment of advanced colorectal carcinoma.
Cancer investigation 1992;10(6):497-504.
1992: Vittorio Gebbia; roberto valenza; Antonio Testa; G Zerillo; S Restivo; G Cupido; F Ingria; G Spadafora; C Barbaccia; G Cannata
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancer.
Medical oncology and tumor pharmacotherapy 1992;9(4):165-8.
1991: Vittorio Gebbia; Antonio Russo; Nicola Gebbia; roberto valenza; Antonio Testa; Sergio Palmeri; Luciano Rausa
Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy.
In vivo (Athens, Greece) 1991;5(6):579-81.
1991: Sergio Palmeri; Vittorio Gebbia; Antonio Russo; Nicola Gebbia; Maria Meli; Luciano Rausa
Cyclophosphamide plus epidoxorubicin and 5-fluorouracil with folinic acid as a novel treatment in metastatic breast cancer: preliminary results of a phase II study.
Journal of chemotherapy (Florence, Italy) 1991;3(3):176-9.
1991: Sergio Palmeri; Vittorio Gebbia; Antonio Russo; Nicola Gebbia; Y Rustum; Luciano Rausa; Patrick J Creaven; N Petrelli
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma.
Journal of chemotherapy (Florence, Italy) 1991;3(3):170-5.
1991: Vittorio Gebbia; Sergio Palmeri; roberto valenza; Luciano Rausa; P Citarrella
The in vivo effects of recombinant human erythropoietin on cisdiamminodichloroplatinum-induced anemia in golden Syrian hamsters.
In vivo (Athens, Greece) 1991;5(2):149-52.
1991: Sergio Palmeri; Vittorio Gebbia
Combined 5-fluorouracil and recombinant alpha-2a-interferon vs. 5-fluorouracil alone in metastatic colorectal carcinoma: a multicenter randomized study.
Journal of surgical oncology. Supplement 1991;2():134-6.
1991: Luciano Rausa; Antonio Russo; Vittorio Gebbia; Nicola Gebbia; Natale D'Alessandro; Sergio Palmeri
Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
Journal of cancer research and clinical oncology 1991;117(3):266-8.
1991: Cesare Gridelli; R Pepe; Sergio Palmeri; S Iacobelli; Mattia Gentile; Vittorio Gebbia; C Garufi; G Airoma; Giovannella Palmieri; A Russo
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1991;28(5):405-7.
1990: Vittorio Gebbia; roberto valenza; Luciano Rausa
The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells.
Anticancer research 1990;10(6):1779-82.
1990: Sergio Palmeri; Vittorio Gebbia; Luciano Rausa
5-Fluorouracil and recombinant alpha interferon-2a in the treatment of advanced colorectal carcinoma: a dose optimization study.
Journal of chemotherapy (Florence, Italy) 1990;2(5):327-30.
1990: Vittorio Gebbia; Nicola Gebbia; Luciano Rausa; Saul J Sharkis; W S May
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 1():103-4.
1990: P Citarrella; Vittorio Gebbia; S Miceli; Sergio Palmeri; Luciano Rausa
Effect of human granulocyte colony stimulating factor (G-CSF) and reduced glutathione (GSH) on drug-induced leukopenia in golden Syrian hamsters.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 1():99-100.
1990: S Palmeri; Vittorio Gebbia; A Russo; M G Armata; Nicola Gebbia; Luciano Rausa
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.
British journal of cancer 1990;61(3):475-8.
1990: S Palmeri; A Russo; Vittorio Gebbia; Nicolò Borsellino; Nicola Gebbia; Y Rustum; Luciano Rausa
A phase I-II study on the toxicity and therapeutic efficacy of 5-fluorouracil in combination with leucovorin and cisplatinum in patients with advanced colorectal carcinoma.
Journal of chemotherapy (Florence, Italy) 1990;2 Suppl 1():28-32.
1990: Calogero Caruso; M A Modica; Giuseppina Candore; C Di Giulio; Aldo Galluzzo; C Giordano; P Di Marco; Vittorio Gebbia; M Tamone Reyes; P Citarrella
Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients.
Bollettino dell'Istituto sieroterapico milanese 1990;69(1):335-8.
1989: Vittorio Gebbia; V Miserendino; S Miceli; A Colucci; M T Reyes; Luciano Rausa; P Di Marco; P Citarrella
Analysis of human dysplastic haematopoiesis in long-term bone marrow culture.
Blut 1989;59(5):442-8.
1989: Sergio Palmeri; Vittorio Gebbia; Antonio Russo; Nicola Gebbia; Luciano Rausa
Combination chemotherapy with cyclophosphamide, doxorubicin and vincristine in the treatment of stage III-IV small-cell lung cancer.
Journal of chemotherapy (Florence, Italy) 1989;1(5):346-9.
1989: Vittorio Gebbia; R Bonaccorso; M Tambone Reyes; V Di Salvo; P Di Marco; P Citarrella
Treatment of polycythemia vera with hydroxyurea.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1278-80.
1989: M Tambone Reyes; R Bonaccorso; Vittorio Gebbia; D Tinnirello; V Di Salvo; Antonio Ciulla; P Di Marco; Serafino Mansueto; P Citarrella
Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukemias and myelodysplastic syndromes.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1276-8.
1989: R Bonaccorso; M Teresi; Vittorio Gebbia; M Tambone Reyes; D Tinnirello; P Di Marco; P Citarrella; Serafino Mansueto
Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1266-8.
1989: M Tambone Reyes; Vittorio Gebbia; M Teresi; R Bonaccorso; A Colucci; L Quartararo; P Di Marco; P Citarrella; Serafino Mansueto
Alpha interferon in the treatment of hairy cell leukemia.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1264-5.
1989: Vittorio Gebbia; A Colucci; P Citarrella; P Di Marco; V Miserendino; M Tambone Reyes; M Teresi; R Bonaccorso; Luciano Rausa; Serafino Mansueto
The multipotential hematopoietic growth factors, bryostatins, inhibit human leukemia cell lines in vitro.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1161-3.
1989: R Bonaccorso; Vittorio Gebbia; M Tambone Reyes; M S Pappalardo; S Peralta; M La Iuppa; M Teresi; P Di Marco; P Citarrella; Serafino Mansueto
Thymopentin (TP 5) in the management of patients with uremia.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):465-6.
1989: Vittorio Gebbia; Sergio Palmeri; Antonio Russo; Nicola Gebbia; Luciano Rausa
The effectiveness of combination chemotherapy with cisplatinum and etoposide in the treatment of advanced non-small cell lung cancer.
Journal of chemotherapy (Florence, Italy) 1989;1(3):203-6.
1989: Sergio Palmeri; Vittorio Gebbia; Antonio Russo; Nicola Gebbia; D Oliveri; Luciano Rausa
Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients.
Journal of cancer research and clinical oncology 1989;115(6):579-82.